Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 45.6% |
| 2 | Technology | 19.83% |
| 3 | Financials | 7.37% |
| 4 | Consumer Discretionary | 6.6% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NBIS
3126
Nebius Group N.V.
NBIS
$63.8B
| $1.26M | ﹤0.01% |
22,861
-416,079
| -95% | -$14.3M |
2013 Q4
46 quarters
|
|
3127
Ichor Holdings
ICHR
$2.4B
| $1.26M | ﹤0.01% |
64,404
+21,830
| +51% | +$400K |
2016 Q4
34 quarters
|
|
|
KC
3128
Kingsoft Cloud Holdings
KC
$2.78B
| $1.26M | ﹤0.01% |
+100,775
| New | +$1.3M |
2025 Q2
0 quarters
|
|
3129
CALL
Blackrock
BLK
$164B
| $1.26M | ﹤0.01% |
+1,200
| New | +$1.13M |
2025 Q2
0 quarters
|
|
|
GOOD
3130
Gladstone Commercial Corp
GOOD
$631M
| $1.26M | ﹤0.01% |
87,860
+27,776
| +46% | +$394K |
2015 Q4
38 quarters
|
|
|
TRTX
3131
TPG RE Finance Trust
TRTX
$470M
| $1.26M | ﹤0.01% |
162,807
-99,484
| -38% | -$759K |
2021 Q2
16 quarters
|
|
3132
Arbutus Biopharma
ABUS
$919M
| $1.26M | ﹤0.01% |
406,558
+180,393
| +80% | +$599K |
2020 Q4
18 quarters
|
|
3133
Enviri
NVRI
$580M
| $1.26M | ﹤0.01% |
144,722
+44,785
| +45% | +$328K |
2013 Q2
48 quarters
|
|
|
ITOS
3134
DELISTED
iTeos Therapeutics
ITOS
| $1.26M | ﹤0.01% |
125,996
-2,981
| -2% | -$24K |
2022 Q1
13 quarters
|
|
3135
Midland States Bancorp
MSBI
$683M
| $1.26M | ﹤0.01% |
72,482
+15,855
| +28% | +$268K |
2016 Q2
36 quarters
|
|
3136
Civista Bancshares
CIVB
$557M
| $1.26M | ﹤0.01% |
54,105
+8,507
| +19% | +$185K |
2017 Q1
33 quarters
|
|
|
GNTY
3137
DELISTED
Guaranty Bancshares
GNTY
| $1.25M | ﹤0.01% |
29,470
+6,066
| +26% | +$245K |
2017 Q2
32 quarters
|
|
|
UHT
3138
Universal Health Realty Income Trust
UHT
$516M
| $1.25M | ﹤0.01% |
31,189
+14,052
| +82% | +$553K |
2013 Q2
48 quarters
|
|
3139
MediaAlpha
MAX
$512M
| $1.24M | ﹤0.01% |
113,648
+50,500
| +80% | +$487K |
2022 Q1
13 quarters
|
|
3140
Tronox
TROX
$618M
| $1.24M | ﹤0.01% |
245,262
+96,947
| +65% | +$528K |
2013 Q4
46 quarters
|
|
3141
Microvast
MVST
$238M
| $1.24M | ﹤0.01% |
342,323
+342,321
| +17,116,050% | +$1M |
2022 Q1
13 quarters
|
|
3142
uniQure
QURE
$1.59B
| $1.24M | ﹤0.01% |
89,014
+21,270
| +31% | +$286K |
2020 Q2
20 quarters
|
|
3143
Liberty Live Group Series C
LLYVK
$9.11B
| $1.24M | ﹤0.01% |
15,284
-2,567
| -14% | -$189K |
2023 Q4
6 quarters
|
|
3144
Hudbay
HBM
$12.1B
| $1.24M | ﹤0.01% |
116,833
+17,969
| +18% | +$150K |
2023 Q2
8 quarters
|
|
3145
First Bank
FRBA
$438M
| $1.24M | ﹤0.01% |
79,858
+21,955
| +38% | +$318K |
2017 Q4
30 quarters
|
|
3146
Peapack-Gladstone Financial
PGC
$787M
| $1.24M | ﹤0.01% |
43,728
+15,183
| +53% | +$417K |
2013 Q2
48 quarters
|
|
3147
Arcturus Therapeutics
ARCT
$377M
| $1.23M | ﹤0.01% |
94,793
+47,266
| +99% | +$559K |
2019 Q3
23 quarters
|
|
3148
FTAI Infrastructure
FIP
$313M
| $1.23M | ﹤0.01% |
199,815
+74,294
| +59% | +$376K |
2023 Q1
9 quarters
|
|
3149
Manitowoc
MTW
$857M
| $1.23M | ﹤0.01% |
102,136
+32,790
| +47% | +$322K |
2013 Q2
48 quarters
|
|
3150
State Street SPDR Dow Jones Global Real Estate ETF
RWO
$1.16B
| $1.23M | ﹤0.01% |
27,771
+1,479
| +6% | +$64.4K |
2020 Q2
20 quarters
|
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2025 filing shows 461 new, 2,914 increased, 1,345 reduced and 463 closed positions. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M. The largest sale was Honeywell, an estimated $1.54B.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.